Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
Goodman S, Hill C, Bata I, Fung A, Higginson L, Lam J, Massel D, McCans J, Nasmith J, Stanton E, Thompson C, Warnica W, Langer A. Goodman S, et al. Among authors: mccans j. Can J Cardiol. 1996 Nov;12(11):1183-90. Can J Cardiol. 1996. PMID: 9191511 Clinical Trial.
Bevantolol disposition in patients with hepatic cirrhosis.
Nattel S, Lawand S, Matthews C, McCans J. Nattel S, et al. Among authors: mccans j. J Clin Pharmacol. 1987 Dec;27(12):962-6. doi: 10.1002/j.1552-4604.1987.tb05597.x. J Clin Pharmacol. 1987. PMID: 2893814
39 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page